UniQure N.V. Announces the Appointment of Leonard E. Post to Its Board of Directors
June 17, 2020 at 04:05 pm EDT
uniQure N.V. announced the appointment of Leonard E. Post to its Board of Directors. Dr. Post, who will also chair the Company’s Research & Development Committee, has extensive biotechnology industry experience including previous global R&D leadership roles at BioMarin and Onyx Pharmaceuticals. Since 2016, Dr. Post has served as Chief Scientific Officer of Vivace Therapeutics and its sister company, Virtuoso Therapeutics, both of which are developing oncology therapeutics.